As a possible justification, some studies reported increased adropin levels following hyperglycemia [7, 81, 105, 106], and since none of the included studies examined newly diagnosed patients, the observed decreased adropin levels may be due to damage to the organs responsible for the production of adropin, which is also targeted for diabetes, such as the pancreas or liver. Here, ENHO is linked to diabetes mellitus.